LANSOPRAZOLE
NDC 68382-772, LANSOPRAZOLE, tablet, orally disintegrating, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-772
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200816
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANSOPRAZOLE30 mg/1
Pharmacologic classes
Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-772-77 | 68382077277 | 10 BLISTER PACK in 1 CARTON (68382-772-77) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (68382-772-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9b3869ad-f2f7-4954-b75c-5c23b8951635NADAC price for package 68382077277
GET /v1/drugs/nadac/68382077277
Use it
Look up 68382-772 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-772. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.